This paper provides a review of recent advances in the understanding and management of acute pancreatitis. The mortality of acute severe pancreatitis remains disappointingly high. While there have been relatively few recent advances in the surgical management of acute pancreatitis, several nonsurgical developments appear promising.
The overall mortality of acute necrotlSlng pancreatitis remains disappointingly high. Intensive Care support, newer antibiotics and the development of ultrasonography and computerised tomographic (CT) scanning have permitted earlier detection of complications, allowed pancreatic masses and fluid collections to be serially monitored, and thus reduced early mortality. It is the late septic complications which continue to have a high mortality of between 40-90070, I depending on the severity of the pancreatitis. While the list of causative factors associated with acute pancreatitis continues to grow, the pathogenesis of the disease is still unknown. Despite considerable effort to find a more sensitive biochemical marker specific for acute pancreatitis, the serum amylase remains the most reliable way of diagnosing acute pancreatitis short of laparotomy. 2 Many of the more controversial issues in the management of acute pancreatitis have only recently been evaluated in controlled clinical trials. This has been possible largely because of the development of reliable noninvasive means of predicting disease severity, 3 thus permitting criticial evaluation of the literature. The purpose of this paper is to review recent developments in acute severe pancreatitis. Ranson 3 and Imrie 4 used statistical analyses to correlate a number of variables with the severity of the attack of acute pancreatitis, the incidence of complications, and the ultimate survival. Their findings can be summarised as follows:
Severity of acute pancreatitis
Severe attacks of pancreatitis tend to occur in patients over 55 years of age who have evidence of circulatory and renal failure, hyperglycaemia, hypocalcaemia, hypoalbuminaemia, leucocytosis of over 16,000 per cubic mm, a fall in haematocrit, and an arterial PO z less than 60 mmHg breathing air. The presence of three or more of these parameters on admission or within 48 hours, usually implies a severe (necotising) pancreatitis, and it is associated with a high risk of death or major complication. The serum amylase level does not correlate with disease severity.
Incidence
The incidence of acute pancreatItIs varies geographically, and is related to aetiological factors such as gallstones and alcohol intake. The incidence of acute pancreatitis in Australia is probably similar to that in the United States, where the disease is related more commonly to alcohol intake than to gallstones. In the United States, the overall prevalence of acute pancreatitis is 'approximately 0.5070; in the United Kingdom, where the disease is much more commonly associated with gallstones, the incidence is between 50-100 cases per million population per annum. Alcoholic pancreatitis is common in males under 50 years, while biliary pancreatitis tends to occur in females over the age of 50. Postoperative and alcoholic pancreatitis have a higher mortality than biliary or idiopathic forms.5
Aetiology
There are many causative factors ih the pathogenesis of acute pancreatitis (Table 1) , but the mechanisms by which these associated factors trigger pancreatitis are not well understood.
About 750/0 of cases of acute pancreatitis are associated with alcohol ingestion and gallstones. Regardless of the clinical cause, the pathologic findings in acute pancreatitis are similar, and represent a spectrum of damage ranging from oedematous pancreatitis, which is usually a mild and self-limited disorder, to necrotising pancreatitis, in which the degree of pancreatic necrosis correlates with the severity of the attacks and its complications.
In South Australia, alcoholism is the commonest associated causative factor and was present in 33 % cases in one series. 6 Although the majority of alcoholics do not develop pancreatitis, most who develop pancreatitis do so only after a six-to ten-year period of heavy drinking. Chronic alcohol ingestion has been shown to lead to secretory and eventual structural changes in the pancreas. 7 Patients with acute alcholic pancreatitis frequently have normal serum amylase levels. 8 Although the association between gallstones and acute pancreatitis is well recognised, only rarely can a stone blocking the common entrance of the biliary and pancreatic ducts be demonstrated. 6 Ranson 3 noted the high incidence (85%-94%) of gallstones in the faeces of patients recovering from gallstone pancreatitis, and suggested that the passage of stones through the ampulla of Vater may initiate acute pancreatitis. In Bennett's series,6 gall-bladder disease was found in 14% of patients, although a much higher incidence was noted in a Queensland survey. 9 Postoperative pancreatitis following abdominal surgery accounts for 1-6% cases of acute pancreatitis. Delay and difficulty in making the diagnosis because of wound pain and tenderness results in a higher mortality than in other forms of acute pancreatitis. Although pancreatitis may be the presenting feature of hyperparathyroidism preoperatively, it is not widely recognised that pancreatitis may occur following parathyroidectomy. 10 Acute pancreatitis is an occasional complication of ERCP with an incidence of 1-7%.
Hyperlipidaemia occurs in about 1 % of cases of acute pancreatitis, but the relationship between cause and effect remains incompletely understood; the serum amylase is often falsely low. Acute pancreatitis has been associated with Types I, IV and V hyperlipoproteinaemias, and these can antedate and apparently cause acute pancreatitis. Ingestion of large amounts of ethanol may cause a moderate hypertriglyceridaemia; most patients with hyperlipidaemia and pancreatitis are alcoholics who have been drinking heavily just prior to the onset of pancreatitis or have a preexisting hyperlipoproteinaemia. The most common lipoprotein abnormality is a Type V (elevated chylomicrons and VLDL). Hypertriglyceridaemia may also result from acute pancreatitis and on recovery may clear completely.
In the face of life-threatening complications such as shock, renal or respiratory failure, where the hyperlipidaemia does not clear, plasma exchange may be beneficial. 11 Pancreatitis occurs in from 7 -19070 of patients with hyperparathyroidism,12 as well as in patients with hypercalcaemia from other causes, including multiple myeloma, sarcoidosis and vitamin 0 intoxication. Again, the pathogenesis of pancreatitis in hypercalcaemia is unknown; the differing histology between experimentally induced hypercalcaemic pancreatitis and that seen in clinical pancreatitis is as yet unexplained.
About 3% of renal transplant patients develop acute pancreatitis and potential causative factors include surgery, drugs (corticosteroids, azathiprine, diuretics), hypercalcaemia and viral infections.
Acute pancreatitis may occur in association with acute fatty liver of pregnancy as well as in otherwise uncomplicated pregnancy which is most often associated with cholelithiasis.
Hereditary pancreatitis is a rare condition of unknown cause thought to be transmitted by a non-X-linked autosomal dominant gene. Most of these patients do not have any other associated ca usati ve factors and are not alcoholics.
The acute pancreatitis occurring in association with infections is usually selflimited and does not result in complications.
Although a large number of drugs have been reported to cause pancreatitis, 13 it is often uncertain whether the underlying disease being Anaesthesia and lmens;ve Care, Vol. 13, No. 3, Augusr, 1985 treated or the actual drugs administered induced the pancreatitis.
Carcinoma of the pancreas is a rare cause of acute pancreatitis (2%).
In patients with recurrent bouts of acute pancreatitis without obvious cause, one should consider occult disease of the biliary tree or pancreatic ducts, drugs or hyperlipidaemia as potential underlying causative factors.
Pathogenesis
The most popular pathogenetic theory currently is that of autodigestion; this theory proposes that proteolytic enzymes (trypsinogen, chymotrypsinogen, proelastase, and phospholipase A) are activated within the pancreas rather than in the intestinal lumen ( Figure 1) . The mechanism of activation of the proteolytic enzymes remains an enigma. Activated proteolytic enzymes, especially trypsin, not only digest pancreatic and peripancreatic tissues but also can activate other proteolytic enzymes such as phospolipase and elastase. Many of the speculations concerning human pancreatitis are based on animal models of necrotising pancreatitis. Whilst it is reasonable to assume that the more severe pathologic lesions found in necrotising pancreatitis are due to autodigestion, it is difficult to invoke this theory in the oedematous variety.
Bile reflux into the pancreatic duct may also result in activation of enzymes as shown in Figure 1 . This is normally prevented by the pancreatic duct pressure which exceeds that in the common bile duct; also, a common channel with free communication between the common bile duct and main pancreatic duct is infrequently found.
Hypoxia of the pancreas due either to a reduction in regional pancreatic blood flow or to systemic hypoxia can precipitate acute pancreatitis. 14 Although there is experimental evidence of increased survival in animals following therapy to improve pancreatic blood flow, 15 the evidence is not convincing enough to warrant the routine use of vasoactive drugs in human acute pancreatitis.
Clinical Features
The main presenting symptom noted in over 90070 of patients is pain -mild, moderate or severe -usually hypochondrial, but sometimes felt only low in the abdomen or in the flanks. The pain may radiate to the back and chest and thus may confuse the diagnosis. Typically, the pain which may be provoked by a large meal or by alcohol, is gradual in onset rather than instantaneous, its duration is days rather than hours, and its pattern is steady and boring rather than undulating. The supine position often worsens the pain, and many patients gain relief by assuming a sitting position with the hips and knees flexed. Painless acute pancreatitis may also occur. 6 Nausea, vomiting and abdominal distension due to gastric and intestinal hypomotility and chemical peritonitis are also common complaints.
The most severely affected patients may present in coma or shock and have a high mortality. 16 Examination reveals a distressed, anxious patient with tachycardia, tachypnoea, low grade fever and hypotension. Shock is not uncommon, and may result from hypovolaemia, septicaemia or cardiogenic causes. The existence of a "myocardial depressant factor" in patients with acute pancreatitis was initially demonstrated in 1971 by Lovett et al. 17 Since then, several studies have been both successful 18 and unsuccessful 19 in demonstrating a diminution in ventricular performance in patients with pancreatitis. We do know, however, from clinical and experimental studies, that pancreatitis results in a marked activation of the kinin system,20 an increase in prostaglandins,21 and the formation of a substance that increases vascular permeability22 and these mediators may be important in the pathogenesis of the shock syndrome.
Usually the abdomen is slightly distended and diffusely tender, especially in the supraumbilical region. Fifty percent of patients will have abdominal guarding and diminished bowel sounds; occasionally board-like rigidity will be encountered, while other patients with severe pain will have few abdominal signs. Ten to twenty per cent of patients have pulmonary findings which include crepitations, atelectasis, and pleural effusion which is usually left-sided and characteristically has a high amylase. The classical signs of loin staining (Culh:n's sign) or umbilical staining (Grey-Turner's sign) are only rarely seen, but when present, indicate the presence of a severe necrotising pancreatitis. Jaundice is uncommon, and occasionally erythemateous skin nodules due to subcutaneous fat necrosis are found.
Diagnosis
The only infallible means of diagnosing acute pancreatitis is by direct inspection of the gland at laparotomy. Diagnosis is normally made by the combination of an appropriate history and clinical picture, biochemical findings and the exclusion as far as possible of other disease. Despite much effort to find a marker specific for acute pancreatitis, the laboratory test most widely used to support the diagnosis is still the total serum amylase level. 2 Opinions differ as to the degree of elevation required to be diagnostic of acute pancreatitis. Serum amylase starts to rise within 4-6 hours of onset of symptoms, reaches its peak in [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] hours and returns to normal in 2-4 days; not surprisingly, peak levels may easily be missed, especially if the patient presents a day or two after the onset of the disease. If high serum amylase levels persist for more than 4-5 days, pseudocyst should be suspected. The normal range for serum amylase is 70-300 units/litre. Surveys at our institution have shown that when the serum amylase is in the 300-600 units/litre range, about one-third of patients have acute pancreatitis and twothirds have another cause for the hyperamylasaemia.
If the serum amylase exceeds 600 units/litre, some 75% have acute pancreatitis, whilst 25% have another cause (Table 2) .
Unfortunately, there is no correlation between the severity of pancreatitis and the degree of serum amylase elevation. Elevated serum triglycerides may spuriously depress the Several ancillary investigations may support the diagnosis of acute pancreatitis, but there is at present no clinical, laboratory or radiological finding that unequivocally establishes the diagnosis. A leucocytosis of IS,000-20,000 per cubic mm is usual. More severely ill patients may demonstrate haemoconcentration with haematocrit values exceeding SOOJo, due to the loss of intravascular volume. Hyperglycaemia is common and multifactorial in origin: decreased insulin release, increased glucagon release, and increased output of adrenal glucocorticoids and catecholamines are all found. 23 Hypocalcaemia occurs in approximately 2SOJo cases and is thought to be due to an acute functional resistance of bone to physiological levels of parathyroid hormone stimulation during the acute phase of pancreatitis,24 rather than to intraperitoneal saponification of calcium by fatty acids in areas of fat necrosis. Hypomagnesaemia may be present in association with the hypocalcaemia. 25 Hyperbilirubinaemia is found in 10070 patients and tends to parallel the elevated alkaline phosphatase levels also seen. Serum albumin is decreased in about 10070 cases. From 2S-S0OJo of patients have hypoxaemia (Pa02 less than 60 mmHg); this may indicate development of the adult respiratory distress syndrome (ARDS). The electrocardiogram may be abnormal in acute pancreatitis, with ST -T changes which may be confused with myocardial ischaemia.
Plain X-ray of the abdomen is abnormal in one-third of cases and may show a localised ileus, pancreatic calcification or gallstones, but its main value is to exclude pneumoperitoneum, small bowel obstruction and aortic dissection or aneurysm. Ultrasonography is of value in detecting biliary disease, and CT scanning is generally considered to be the investigation of choice for diagnosing the complications of abscess and pseudocyst,26 as bowel distension with gas often interferes with ultrasonic evaluation of the pancreas.
Differential Diagnosis
This should include consideration of the following diseases: Acute pancreatitis should always be considered in patients who present with sudden shock not accompanied by abdominal pain.
Complications
The local and systemic complications of acute pancreatitis are summarised in Table 3 .
Inflammatory masses frequently develop in the first two to three weeks after the onset of pancreatitis. CT scanning is the radiological investigation of choice for diagnosing the local complications,26 but cannot differentiate a sterile fluid collection from an infected collection.
A phlegmon of the pancreas is defined as a I. Local noninfected solid mass of inflamed pancreatic and retroperitoneal tissues often containing areas of pancreatic necrosis. Clinically, a phlegmon may be confused with other pancreatic masses, especially a pseudocyst. Phlegmons typically present as palpable epigastric masses which are solid on ultrasonography and computerised tomography; the CT scan shows a low-density mass similar to that of fluid-filled cysts. They usually resolve in a few weeks with nonsurgical conservative therapy. 27 Pseudocyst occurs in about 4070 of patients and is common in patients with alcoholic pancreatitis. It consists of a collection of fluid and debris rich in pancreatic enzymes in the region of the pancreas. Pseudocysts appear as well-defined rounded areas of low density with a surrounding high-density capsule on the CT scan, and result in pain and weight loss; an abdominal mass is only felt in 50070 of cases. In 30070 of patients with pseudocysts complications (infection, haemorrhage, rupture) occur; thus pseudocysts should be followed with serial scans, and enlarging collections drained. Gas within a pseudocyst is suggestive of secondary infection or fistulous connection with the alimentary tract.
Pancreatic abscess results in toxaemia, fever, and a tender epigastric mass, and occurs in 5-10070 of patients with acute pancreatitis. If bubbles of gas are seen within the pancreas or an extra pancreatic phlegmon, the diagnosis of abscess is confirmed. The treatment is surgical drainage, but the mortality is high (22-57070).3 Severe pancreatitis with the presence of three or more risk factors, postoperative pancreatitis, early oral feeding, early laparotomy and possibly injudicious use of antibiotics predispose to the development of pancreatic abscess.
Pulmonary complications are common in patients with acute pancreatitis,28 some series reporting an incidence of as high as 60070. Acute respiratory failure in acute pancreatitis was considered previously by Cameron in this journal. 29 While the pathogenesis of human ad ult respiratory distress syndrome is still unknown, it is known that in the sheep, acute necrotising pancreatitis results in an increase in pulmonary microvascular permeability to proteins and pulmonary oedema, which is dependent on the presence of circulating neutrophils. 30 In addition, phospholipase A (lecithinase) has been shown to be increased in the blood and pulmonary washings of animals with experimental pancreatitis, bilt the significance of this remains uncertain at the present time. 31 Finally, trypsin can release bradykinin and induce C3 and C5 activation and may have a significant role in the development of ARDS.32 Although hypovolaemia is usually responsible for the development of shock in patients with acute pancreatitis, sepsis and cardiac failure may contribute to the clinical picture and necessitate invasive haemodynamic monitoring with a Swan-Ganz catheter. Several groups have failed to demonstrate the presence of a "myocardial depressant factor", 19.33 and Cobo et al. suggested that the primary cardiovascular abnormality in acute pancreatitis was decreased vascular tone due to flow maldistribution in the peripheral microcirculation. 33 Although mild azotaemia is common in acute pancreatitis, renal failure is not common, occurring in 5-10UJo of cases when no persisting renal disease was present. 34 The renal failure is not always preceeded by hypotension, but is associated with increased renal vascular resistance and relative renal ischaemia.
Disseminated intravascular coagulation may occur in acute pancreatitis and is manifested by thrombocytopoenia, hypofibrinogenaemia and elevated fibrin degradation products. There is also an increased tendency to deep venous thrombosis.
Psychotic disturbance in the form of confusion, delirium, disorientation and hallucinations occurs in about lOUJo of patients. Localising neurological signs are usually absent. This organic brain syndrome may be due primarily to pancreatitis, but hypoxia, delirium tremens, or fat embolism have all been incriminated.
Treatment
In 85-90UJo of patients with acute pancreatitis, the disease is self-limited and subsides spontaneously within a week after commencing treatment. Treatment is both medical and surgical. The aims of treatment are to (1) reduce inflammation and autodigestion of the pancreas, (2) minimise pain, and (3) to prevent and treat complications.
Medical Treatment
Patients with more than three indicators of an adverse prognosis or with complications already obvious on admission should be admitted to the Intensive Care Unit for resuscitation and monitoring. These patients require at least insertion of a, central venous line Anaesthesia and Intensive Care, Vol. 13, No. 3, AuguSl, 1985 and indwelling urinary catheter to facilitate resuscitation. Nasogastric suction and fasting have traditionally been employed in acute pancreatitis; their use is intended to reduce gastric and duodenal distension, minimise vomiting, and decrease pancreatic exocrine stimulation by reducing secretin release. Although controlled studies have failed to demonstrate any therapeutic value of nasogastric suction in patients with mild pancreatitis,35 its use is still recommended in the severe form of the disease because of the rapid symptomatic improvement that usually results.
Appropriate intravenous fluid replacement remains the cornerstone of medical treatment of acute pancreatitis. The aim is to replace the losses incurred by vomiting and sequestration in the peritoneal cavity and retroperitoneum, thus maintaining perfusion but avoiding fluid overload. Detailed consideration of the management of respiratory and cardiac failure is beyond the scope of this article; intravenous crystalloid solutions are given according to clinical requirements and are supplemented when necessary by protein solutions in order to maintain a positive central venous pressure. Oxygen therapy is administered according to arterial blood gas analysis.
The analgesic of choice is pethidine, since unlike the opiates, it does not produce spasm of the ampulla of Vater.
Antibiotics are often administered to patients with acute pancreatitis to reduce infectious complications. Two controlled prospective trials have shown no benefit from antibiotic use in acute pancreatitis of mild severity. 36.37 However, most of these patients had mild acute alcoholic pancreatitis which is known to be associated with a low risk of infective complications, and thus it may be unwise to extrapolate from these studies to all patients. Nevertheless, because secondary infection of necrotic pancreatic tissue or obstructed biliary passages contributes to much of the late mortality, appropriate antibiotic therapy of established infection is clearly important. Broad spectrum cover of both aerobes and anaerobes is needed, and in our institution the combination of gentamicin, amoxycillin and metronidazole is used.
Glucagon,38 the anti-kallikrein drug aprotinin (Trasylol)38 and cimetidine 35 . 39 have been shown in controlled prospective trials to have no clearly demonstrable therapeutic effectiveness.
Recently it has been shown that the antiprotease a-2-macroglobulin is depressed in acute pancreatitis,40 and that the decrease correlated with disease severity. a-2-macroglobulin is a component of preparations of whole plasma and is therefore potentially available for therapy. A recent nonrandomised trial of fresh frozen plasma given in the first five days after onset of acute pancreatitis of various severities showed encouraging results. 41 Parenteral nutrition is of established value in patients with severe pancreatitis. 42 
Surgical treatment
Much of the controversy concerning the management of acute pancreatitis relates to the surgical treatment and will not be considered in detail in this review. In general, there are four main indictions for surgery: 1. uncertain diagnosis, 2. deteriorating condition, 3. biliary pancreatitis, 4. pancreatic abscess. A deteriorating condition implies either the development of peritonitis or a failure to improve with appropriate medical therapy. The indications for surgical intervention with a view to early removal of slough or pancreatic resection are still imprecise. Specific operative measures and their rationale are summarised in Table 4. 3   TABLE 4 Operative measures for acute pancreatitis I. To limit the severity of pancreatic inflammation.
Biliary operations. 2. To interrupt the pathogenesis of complications.
Pancreatic drainage. Pancreatic resections. Peritoneal lavage. 3. To support the patient and treat complications.
Drainage of pancreatic abscesses.
Since the incidence of recurrent acute pancreatitis in patients who survive one episode of gallstone pancreatitis is 30-600/0, many authors suggest the need for definitive biliary surgery once the acute pancreatitis has settled. Peritoneal lavage has not yet been shown to improve the overall survival in acute pancreatitis, despite a reduction in early mortality.
Although ultrasonography and eT scanning have improved the diagnosis of peripancreatic fluid collections, they usually do not differentiate sterile collections, which may resolve with nonoperative treatment, from infected collections that require surgical drainage.
Despite trials of a variety of drainage and resection techniques, the mortality associated with infected pancreatic abscesses is still high, ranging from 22 to 57%. 43 
Conclusion
Ever since the first study of acute necrotising pancreatitis by Fi tz in 1889, clinical management has remained controversial. 44 This is partly due to difficulty in establishing disease severity and until recently this has prevented statistical education of various therapeutic modalities. A variety of nonsurgical measures intended to reduce pancreatic inflammation or interrupt the pathogenesis of complications of acute pancreatitis have been evaluated and none found to be of any significant therapeutic benefit. There is no doubt that intensive care management of patients with severe acute pancreatitis has reduced the early mortality from shock, respiratory and renal failure as has percutaneous peritoneal lavage, but neither prevent the frequently fatal late septic complications of peripancreatic necrosis.
